Advances in influenza virus-like particles bioprocesses-Reference-Cited by-同舟云学术

Advances in influenza virus-like particles bioprocesses

Published:2019-12-02 Issue:12 Volume:18 Page:1285-1300
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Durous Laurent¹^ORCID,Rosa-Calatrava Manuel¹²^ORCID,Petiot Emma¹^ORCID

Affiliation:

1. Virologie et Pathologie Humaine - VirPath team - Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France

2. VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2019.1704262

Reference154 articles.

1. The annual production cycle for influenza vaccine

2. Influenza vaccines based on virus-like particles

3. Influenza virus-like particle vaccines

4. New vaccines against influenza virus

5. Progress in developing virus-like particle influenza vaccines

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual N-linked glycosylation at residues 133 and 158 in the hemagglutinin are essential for the efficacy of H7N9 avian influenza virus like particle vaccine in chickens and mice;Veterinary Microbiology;2024-07

2. Tailored Viral-like Particles as Drivers of Medical Breakthroughs;International Journal of Molecular Sciences;2024-06-18

3. Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects;Biotechnology Advances;2023-12

4. Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems;Pharmaceutics;2023-11-14

5. Influenza and Universal Vaccine Research in China;Viruses;2022-12-30